Spero Therapeutics Inc (NAS:SPRO)
$ 1.03 0.0861 (9.12%) Market Cap: 56.15 Mil Enterprise Value: -20.21 Mil PE Ratio: 12.88 PB Ratio: 0.85 GF Score: 39/100

Q3 2022 Spero Therapeutics Inc Earnings Call Transcript

Nov 14, 2022 / 09:30PM GMT
Release Date Price: $2.03 (+1.50%)
Operator

Good afternoon, and welcome to the Spero Therapeutics Third Quarter 2022 Financial Results Conference Call. (Operator Instructions) Please be advised that this call is being recorded, and a replay will be available.

You can find information on the replay and further information related to today's announcement on the Spero Therapeutics website, www.sperotherapeutics.com.

At this time, I would like to turn the conference call over to Ted Jenkins, Vice President, Investor Relations and Strategic Finance at Spero Therapeutics. Mr. Jenkins, please go ahead.

Ted Jenkins
Spero Therapeutics, Inc. - VP & Head of IR

Thank you, operator, and thank you all for participating in today's conference call. This afternoon, Spero Therapeutics released financial results and provided a pipeline update for the third quarter of 2022. A press release is available on the Investor page of the Spero Therapeutics website.

Before we begin, I'd like to remind you that some of the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot